179 related articles for article (PubMed ID: 28796639)
21. ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis.
Kim CH; Simmons SC; Williams LA; Staley EM; Zheng XL; Pham HP
Transfusion; 2017 Nov; 57(11):2609-2618. PubMed ID: 28646526
[TBL] [Abstract][Full Text] [Related]
22. Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre.
Tufano A; Polimeno M; Matani B; Cardillo G; Capasso F; Mormile R; Paladino F; Di Minno G
Blood Transfus; 2023 Jul; 21(4):345-349. PubMed ID: 35969133
[TBL] [Abstract][Full Text] [Related]
23. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
24. The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis.
Masias C; Cataland SR
Blood; 2018 Aug; 132(9):903-910. PubMed ID: 30006329
[TBL] [Abstract][Full Text] [Related]
25. Multicentric evaluation of the new HemosIL Acustar
Pascual C; Nieto JM; Fidalgo T; Seguí IG; Díaz-Ricart M; Docampo MF; Del Rio J; Salinas R
Int J Lab Hematol; 2021 Jun; 43(3):485-493. PubMed ID: 33264480
[TBL] [Abstract][Full Text] [Related]
26. Pediatric thrombotic thrombocytopenic purpura.
Joly BS; Coppo P; Veyradier A
Eur J Haematol; 2018 Oct; 101(4):425-434. PubMed ID: 29889319
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan.
Matsumoto M; Fujimura Y; Wada H; Kokame K; Miyakawa Y; Ueda Y; Higasa S; Moriki T; Yagi H; Miyata T; Murata M;
Int J Hematol; 2017 Jul; 106(1):3-15. PubMed ID: 28550351
[TBL] [Abstract][Full Text] [Related]
28. Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre.
Grall M; Azoulay E; Galicier L; Provôt F; Wynckel A; Poullin P; Grange S; Halimi JM; Lautrette A; Delmas Y; Presne C; Hamidou M; Girault S; Pène F; Perez P; Kanouni T; Seguin A; Mousson C; Chauveau D; Ojeda-Uribe M; Barbay V; Veyradier A; Coppo P; Benhamou Y
Am J Hematol; 2017 Apr; 92(4):381-387. PubMed ID: 28133771
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state.
Browning S; Bahar B; Lee AI; Gorshein E
Hematology; 2020 Dec; 25(1):473-477. PubMed ID: 33269995
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.
Li A; Bendapudi PK; Uhl L; Hamdan A; Kaufman RM; Makar RS
Transfusion; 2017 Sep; 57(9):2151-2158. PubMed ID: 28635017
[TBL] [Abstract][Full Text] [Related]
31. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
32. ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura.
Mancini I; Ferrari B; Valsecchi C; Pontiggia S; Fornili M; Biganzoli E; Peyvandi F;
Eur J Intern Med; 2017 Apr; 39():79-83. PubMed ID: 27887777
[TBL] [Abstract][Full Text] [Related]
33. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
Yagi H; Matsumoto M; Fujimura Y
Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
[TBL] [Abstract][Full Text] [Related]
34. A modified PLASMIC score including the lactate dehydrogenase/the upper limit of normal ratio more accurately identifies Chinese thrombotic thrombocytopenic purpura patients than the original PLASMIC score.
Zhao N; Zhou L; Hu X; Sun G; Chen C; Fan X; Zhou S; Tao X; Liu H; Zheng C
J Clin Apher; 2020 Apr; 35(2):79-85. PubMed ID: 31724781
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies.
Zini G; De Cristofaro R
Turk J Haematol; 2019 Nov; 36(4):222-229. PubMed ID: 31337190
[TBL] [Abstract][Full Text] [Related]
36. Potential impact of a delayed ADAMTS13 result in the treatment of thrombotic microangiopathy: an economic analysis.
Kim CH; Simmons SC; Wattar SF; Azad A; Pham HP
Vox Sang; 2020 Jul; 115(5):433-442. PubMed ID: 32227485
[TBL] [Abstract][Full Text] [Related]
37. ADAMTS13 Activity: Screening Test Protocol.
Moore GW; Griffiths M; Binder NB
Methods Mol Biol; 2023; 2663():523-531. PubMed ID: 37204734
[TBL] [Abstract][Full Text] [Related]
38. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.
Abdelgawwad MS; Cao W; Zheng L; Kocher NK; Williams LA; Zheng XL
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235
[TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity.
Malak S; Wolf M; Millot GA; Mariotte E; Veyradier A; Meynard JL; Korach JM; Malot S; Bussel A; Azoulay E; Boulanger E; Galicier L; Devaux E; Eschwège V; Gallien S; Adrie C; Schlemmer B; Rondeau E; Coppo P;
Scand J Immunol; 2008 Sep; 68(3):337-44. PubMed ID: 18782260
[TBL] [Abstract][Full Text] [Related]
40. Thrombotic thrombocytopenic purpura: The role of ADAMTS13.
Rogers HJ; Allen C; Lichtin AE
Cleve Clin J Med; 2016 Aug; 83(8):597-603. PubMed ID: 27505881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
